This half-day benchmarking event provides an intimate setting for lawyers and compliance officers to engage in an interactive dialogue on the following topics.
- Brief Update on Global GMP Inspections
- Licensing and Co-promotion Transactions: Regulatory and Compliance Issues
- Antitrust Compliance and Enforcement after the Agency Reorganization
- Evolving Policies and Challenges in the Innovation Era
For more information or questions, please contact email@example.com.
New York and Washington, D.C.
SCOTT BASS heads the firm’s Global Life Sciences team, coordinating pharmaceutical, medical device, food and dietary supplement matters in the United States, Europe and Asia. He is ranked internationally among the top authorities on FDA-related enforcement and regulatory issues and has led audits and investigations involving off-label promotion, pharmacovigilance, PDMA, GMP and fraud and abuse issues, as well as DEA and FTC matters.
Beijing and Shanghai
LEI LI has deep experiences in the life sciences industry, and for over a decade has advised pharmaceutical, medical device and dietary supplement companies in China on a broad range of regulatory matters and commercial and corporate transactions in China, such as product registration, clinical trials, distribution, licensing, co-promotion and co-marketing, and M&A and spin-offs. Mr. Li has been working on antitrust matters in China since the launch of China’s Anti-monopoly Law in 2008, and has accumulated extensive experience in this area. Mr. Li is featured as a leading antitrust lawyer by Chambers Asia-Pacific, IFLR 1000, and China Business Law Journal.
CHEN YANG heads the firm's China Life Sciences practice and her practice focuses on regulatory, corporate and commercial law. She routinely represents international pharmaceutical, medical device and food companies in connection with market entrance, product localization, marketing and promotional activities, product recalls, clinical trials, FCPA/Anti-bribery and other industry-specific regulatory, compliance and enforcement issues, as well as joint ventures, merger and acquisitions, licensing, IP and antitrust matters in the life sciences area. Chen has been featured as a leading life sciences lawyer in China by Chambers and Partners, The Asian Lawyer, Practical Law, IFLR 1000, Who’s Who Legal, etc.